Autophagy is abnormally high in cell lines in culture derived from ductal pancreatic adenocarcinoma (PDAC)

被引：0
|
作者：
Larsen, Christian-Jacques
机构：
来源：
BULLETIN DU CANCER | 2011年 / 98卷 / 07期
关键词：
CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：719 / 722
页数：4
相关论文
共 50 条
  • [1] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [2] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
  • [3] Pancreatic ductal adenocarcinoma (PDAC) early detection
    Hinestrosa, Juan P.
    Dhani, Harmeet
    Schroeder, Gregor
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Keith, Dove
    Sears, Rosalie
    Billings, Paul
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
    Chandana, Sreenivasa
    Babiker, Hani M.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 161 - 177
  • [5] Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN
    Yamaguchi, Koji
    Kanemitsu, Shuichi
    Hatori, Takashi
    Maguchi, Hiroyuki
    Shimizu, Yasuhiro
    Tada, Minoru
    Nakagohri, Toshio
    Hanada, Keiji
    Osanai, Manabu
    Noda, Yutaka
    Nakaizumi, Akihiko
    Furukawa, Toru
    Ban, Shinichi
    Nobukawa, Bunsei
    Kato, Yo
    Tanaka, Masao
    PANCREAS, 2011, 40 (04) : 571 - 580
  • [6] Characterization of cancer stem cells derived from pancreatic ductal adenocarcinoma cell lines and generation of three-dimensional culture models
    Biondani, G.
    Dando, I.
    Dalla Pozza, E.
    Costanzo, C.
    Zeeberg, K.
    Cardone, R. A.
    Greco, M. R.
    Marengo, A.
    Arpicco, S.
    Reshkin, S. J.
    Palmieri, M.
    FEBS JOURNAL, 2014, 281 : 777 - 777
  • [7] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    LABORATORY INVESTIGATION, 2018, 98 : 680 - 680
  • [8] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
  • [9] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] The Beginning of the End of Nihilism in Pancreatic Ductal Adenocarcinoma (PDAC)?
    Johnson, K. M.
    Firpo, M. A.
    Boucher, K. M.
    Scaife, C. L.
    Mulvihill, S. J.
    PANCREAS, 2013, 42 (08) : 1357 - 1357
12345